AIM Self-Assessment: Volume One

Price: $199 for College Members, $299 for non-members

Note: Enrollments for the course are now closed as this course will expire as of July 5, 2023. After this date, enrollees will no longer be able to access the course or claim credit. Please plan on completing the course prior to its expiration on July 5, 2023.

College membership is free for Fellows-in-Training

You can earn up to 22 AMA PRA Category 1 Credit(s)™. 

This first Allergy & Immunology Medicine self-assessment module is designed to help allergy/immunology providers obtain new knowledge, as well as reaffirm existing knowledge. It also helps allergists/immunologists evaluate and maintain their clinical competence. The module consists of 108 case-based, multiple-choice questions. Comprehensive discussions provide evidence-based explanations regarding all answer options, as well as provides supporting references from the current literature. The questions address two areas of study (basic science and clinical science) and nine categories (immune mechanisms, cells involved in immune response, immunological disorders, non-disease specific pharmacology/therapeutics, anatomy/physiology/pathology, research principles, hypersensitivity disorders, specific diagnostic modalities, and allergens/antigens).

There are 4 modes within this module: Pretest, Learn, Posttest and Comparison.

Pretest: This initial self-audit allows for one to identify their gaps in knowledge related to established knowledge in allergy and immunology. Answer each question once and receive a Pretest Score at the end.

Learn: This study mode allows one to answer questions, review evidence-based discussions, and link to PubMed abstracts of the references. Answer each question until the correct answer is chosen, then read the discussion and view the references. If you answer incorrectly, you will be given a brief statement on why that answer choice is incorrect. The comprehensive discussion includes rationale for all answer options, whether they are correct or incorrect.

Posttest: This final audit allows one to measure the amount of learning that has occurred. Answer each question once and receive a Posttest Score at the end. One has 3 attempts to achieve a passing score of 80% or better.

Comparison: This final mode provides a comparison chart showing one’s pretest vs posttest scores, and a peer-to-peer comparison that shows how one compares to their colleagues answering the same questions.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 22 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAI designates this program for 22 ABAI MOC Part II (Self-Assessment) credits.

Commercial Support
There is no commercial support for this activity.

Target Audience

Practicing Allergy/Immunology Providers and Fellows in Training.

Learning Objectives

At the conclusion of this course, participants should be able to:

  • Identify, evaluate and manage current concerns and issues related to the pathophysiology, diagnosis and treatment of allergic and immunologic diseases
  • Demonstrate a mastery of key concepts in allergy and immunology
  • Summarize the practical application of key concepts in allergy and immunology in the management of clinical problems
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
  
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.
Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.
Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 22.00 AMA PRA Category 1 Credit™
  • 22.00 Attendance
  • 22.00 MOC
Course opens: 
07/06/2020
Course expires: 
07/05/2023
Cost:
$299.00
Rating: 
5

Gerald Lee, MD Editor in Chief
Dr. Lee is an associate professor of pediatrics and internal medicine at Emory University School of Medicine. He has multiple roles in medical education, including allergy/immunology fellowship program director, medical school immunology thread director, and editor in chief of the ACAAI AIM self-assessment and board review book.
Disclosures: Nothing to disclose

Justin Greiwe, MD, FACAAI
Dr. Greiwe received his medical degree from the University of Toledo College of Medicine followed by pediatric residency at University Hospitals Rainbow Babies & Children’s Hospital in Cleveland and Allergy & Immunology fellowship at Cleveland Clinic. He is a partner at Bernstein Allergy Group, is a principle investigator at Bernstein Clinical Research Center and is a clinical Assistant Professor of Medicine at University of Cincinnati. 
Disclosures: Speaking/Teaching Honorarium: Astra Zeneca; Sanofi Genzyme Regeneron; Advising/Consulting Fee: Astra Zeneca

Fatima Khan, MD
Dr. Khan is boarded in both Internal Medicine and Pediatrics and provides clinical Allergy/Immunology services for Ann & Robert H. Lurie Children's Hospital Division of Allergy/Immunology in Chicago, IL. She has published in allergy journals and recently authored a chapter on allergic rhinitis and sleep. 
Disclosures: Nothing to disclose

Min Jung Lee, MD
Dr. Lee is board certified fellow of the American Academy of Allergy, Asthma and Immunology and currently an Assistant Professor of Pediatrics and Internal Medicine in the Division of Allergy and Immunology at UT Southwestern Medical Center. 
Disclosures: Nothing to disclose

Ray Rodriguez, MD, JD, MPH, MBA
Dr. Rodriguez serves as the Chief Medical Officer (CMO) and Director of Pediatric Allergy and Immunology at the Mississippi Center for Advanced Medicine. He holds a Medical Degree (M.D.) from Ponce School of Medicine in Puerto Rico, Juris Doctor (J.D.) from the University of Puerto Rico Law School, Master in Public Health (MPH) from the University of Puerto Rico and a Master in Business Administration (MBA) from the University of Tennessee. Dr. Rodriguez completed his Pediatric Residency from William Beaumont Army Medical Center in El Paso, Texas, his Allergy Immunology and Clinical Laboratory Immunology Fellowships from Walter Reed Army Medical Center in Washington, DC.
Disclosures: Speaker/Teaching Honorarium: Takeda (formerly Shire Pharmaceuticals)

Meagan Shepherd, MD, FACAAI
Dr. Shepherd is an Associate Professor at Marshall University Department of Pediatrics, where she also serves as the Associate Program Director for the Pediatrics and Med-Peds Residency Programs. Her clinical interests lie in immunodeficiency, serving underserved populations, and conducting research that will benefit her patients. 
Disclosures: Intellectual Property Rights: Ohio State University/Nationwide Children's Hospital

Jennifer Shih, MD
Dr. Shih is an Assistant Professor of Pediatrics and Internal Medicine at Emory University School of Medicine. Dr. Shih also serves as the Medical Director of Pediatric Allergy Clinics and the Associate of Adult Asthma, Allergy, and Immunology Program.
Disclosures: Advisory/Committee Member Fee: Takeda; Teva;

Kristin Sokol, MD, MS, MPH, FACAAI
Dr. Sokol is a board-certified allergist/immunologist and board-certified pediatrician specializing in the care of both adult and pediatric patients with a variety of allergic and immunologic disorders at Schreiber Allergy in the DC area. Prior to this, she was an assistant professor at the University of Texas Medical Branch and at Beth Israel Medical Center. She was a staff clinician at the NIH from 2017-2019 where she treated patients and performed research in the field of food allergy and the genetics of allergic disease. 
​​​​​​​Disclosures: Speaker/Teaching Honorarium: Sanofi Genzyme Regeneron

Gary C. Steven, MD, PhD, CPI, FACAAI
Dr. Steven has owned and operated a solo, independent allergy practice in Milwaukee, Wisconsin since 2003. He currently serves on the Board of Regents of the ACAAI and is the Chair of the Accreditation & Certification Committee.
Disclosures: See attached

Gregory R. Toci, DO
Dr. Toci is in private clinical practice with Advocare Allergy & Asthma in Marlton, New Jersey. He is currently a member of the ACAAI Accreditation & Certification Committee and previously was a member of the ACAAI and AAAAI Sports Medicine Committees. 
Disclosures: Speaker/Teaching Honorarium: Sanofi Genzyme Regeneron

Eric Yen, MD, MS
Dr. Yen is a Health Sciences Assistant Clinical Professor at UCLA Medical Center/David Geffen School of Medicine at UCLA. He practices as an allergist, immunologist, and pediatric rheumatologist in Santa Monica and Torrance seeing patients with allergic, immunodeficiency and autoimmune disorders.
Disclosures: Nothing to disclose

 

 

 

 

 

 

Available Credit

  • 22.00 AMA PRA Category 1 Credit™
  • 22.00 Attendance
  • 22.00 MOC

Price

Cost:
$299.00
Please login or create an account to take this course.